After an experimental treatment for Hep C nearly kills him, Wes quits NorBAC to enroll in a cutting edge HCV program in Stockholm; a racist city councilor claims his daughter was poisoned by Muslim extremists; the FDA is willing to fast-track some drugs in order to save an immune-deficient woman who was infected with smallpox.
